Moving goods into, out of, or through Northern Ireland
Moving goods into, out of, or through Northern Ireland.
On 10 December the Co-Chairs of the Withdrawal Agreement Joint Committee reached an agreement in principle to address the outstanding issues related to the implementation of the Withdrawal Agreement, in particular the Northern Ireland Protocol.
The Northern Ireland Protocol Command Paper outlines further details; as well as further information on the UK Government’s work to implement the Protocol and support businesses as it comes into force. This paper was laid in Parliament on 10 December.
The decisions contained in the Co-Chairs agreement in principle were agreed to at the Joint Committee meeting on 17 December.
There is also information available on Northern Ireland Executive owned sites where policy is devolved, for example, the NI Department for Agriculture, Environment and Rural affairs’ Landing Page.
The government has launched the free-to-use Trader Support Service which will help businesses and traders prepare for the changes that will affect your business if you move goods into and out of Northern Ireland.
Register for the Trader Support Service
The Movement Assistance Scheme will help businesses to meet new requirements for moving animals, plants and associated products from Great Britain to Northern Ireland. This includes advice to businesses through a dedicated helpline and means traders will not need to pay certification costs.
Trader support
Customs, VAT, Excise
Regulation of goods including manufactured goods
Agri-food and drink
Food Standards Agency:
- Export or move live animals
- Export or move livestock and poultry
- Export or move composite food products
- Export or move animal bones, protein and other by-products
- Export or move animal germplasm (semen, ova and embryos)
- Export or move animal feed or pet food
- Export horses and ponies: special rules
- Importing and exporting plants and plant products
- Exporting or moving fish from the UK
- Importing or moving fish to the UK
- Export groups of products of animal origin: use 30-day support attestations to prove health and traceability
- Food standards: labelling and composition
- Food labelling: country of origin
- Poultry meat marketing standards
- Beef and veal marketing standards
- Hatching eggs and chicks marketing standards
- Hops and hop products marketing standards
- Protected geographical food and drink names: UK GI schemes
- Import or export endangered species: check if you need a CITES permit
- Importing and exporting organic food
- Veterinary businesses: working after Brexit transition
- Wood packaging material for import and export
Environmental standards
Medicines and healthcare
- Supplying authorised medicines to Northern Ireland
- Sourcing medicines for the UK Market
- Importing investigational medicinal products into Great Britain from approved countries
- Import a human medicine
- Acting as a Responsible Person (import)
- Regulating medical devices in the UK
- Quality and safety of human organs, tissues and cells
- Quality and safety of human blood and blood products
- E-cigarettes: regulations for consumer products
- Variations to Marketing Authorisations (MAs)
- Exporting active substances manufactured in Great Britain for use in EEA and Northern Ireland
- Guidance on the handling of applications for Centrally Authorised Products (CAPs)
- Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
- Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs), 'grandfathering' and managing lifecycle changes
- How Marketing Authorisation Applications referred under Article 29 are handled
- Converting Parallel Distribution Notices (PDNs) to UK Parallel Import Licences (PILs)
- Guidance on new provisions for traditional herbal medicinal products and homeopathic medicinal products
- Reference Medicinal Products (RMPs)
- Renewing Marketing Authorisations for medicines
- Guidance on licensing biosimilars, ATMPs and PMFs
- Comparator products in Bioequivalence/Therapeutic Equivalence studies
- Guidance on substantial amendments to a clinical trial
- Guidance on pharmacovigilance procedures
- Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)
- Register to make submissions to the MHRA
- Webinars: information on how to make submissions to the MHRA
- Procedures for UK Paediatric Investigation Plan (PIPs)
- Completed Paediatric Studies - submission, processing and assessment
- Format and content of applications for agreement or modification of a Paediatric Investigation Plan